In this episode, Ron Lanton draws on insights from the JP Morgan Healthcare Conference to explain how healthcare investment is shifting from backing novel ideas to funding organizations that can scale, survive regulatory and reimbursement pressure, and embed technology into the operational infrastructure of care delivery.

The Ron Lanton Report: From Innovation to Infrastructure

<div>The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and <a href="http://PharmExec.com">PharmExec.com</a> to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry. </div>

Science

Life Sciences

The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry.

The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and <a href="http://PharmExec.com" rel="noopener noreferrer">PharmExec.com</a> to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry.&nbsp;

Share The Ron Lanton Report: From Innovation to Infrastructure

Sign up to save your podcasts

The Ron Lanton Report: From Innovation to Infrastructure

The Ron Lanton Report: From Innovation to Infrastructure

More shows like Pharmaceutical Executive

Planet Money

Economist Podcasts

Motley Fool Hidden Gems Investing

WSJ Your Money Briefing

WSJ What’s News

Bloomberg Businessweek

WSJ Tech News Briefing

HBR IdeaCast

Bold Names

The Indicator from Planet Money

The Readout Loud

Thoughts on the Market

The Journal.

Bloomberg Daybreak: US Edition

WSJ's Take On the Week